A review of the use of ketorolac tromethamine 0.4% in the treatment of post-surgical inflammation following cataract and refractive surgery

The non-steroidal anti-inflammatory drug (NSAID) ketorolac tromethamine 0.4% ophthalmic solution, a recent reformulation containing 20% less active ingredient that the original formulation, is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery. Clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandoval, Helga P, Fernández de Castro, Luis E, Vroman, David T, Solomon, Kerry D
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704525/
https://www.ncbi.nlm.nih.gov/pubmed/19668513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704525/
https://www.ncbi.nlm.nih.gov/pubmed/19668513

Ejemplares similares